small molecule

KAPSPARGO SPRINKLE

METOPROLOL SUCCINATE

Loss of exclusivityJuly 2035latest FDA-listed patent expiry
CompanySUN PHARMA INDUSTRIES LTD

Drug detail

Brand nameKAPSPARGO SPRINKLE
Active ingredientMETOPROLOL SUCCINATE
StrengthEQ 25MG TARTRATE
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2018
Marketing statusRX

Listed patents

PatentExpiresType
9504655July 2035product
9700530July 2035product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

KAPSPARGO SPRINKLE patent cliff — loss of exclusivity July 2035 | CliffBio